Literature DB >> 30715937

Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.

Niccolò Maurizi1, Michelle Michels2, Ethan J Rowin3, Christopher Semsarian4, Francesca Girolami1, Benedetta Tomberli1, Franco Cecchi1, Martin S Maron3, Iacopo Olivotto1, Barry J Maron3.   

Abstract

Entities:  

Keywords:  cardiomyopathy, hypertrophic; echocardiography; electrocardiography; genetics; hypertrophy, left ventricular; mortality

Mesh：

Year:  2019        PMID： 30715937     DOI： 10.1161/CIRCULATIONAHA.118.037264

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  Targeted Medical Therapies for Hypertrophic Cardiomyopathy.

Authors:  Carlo Fumagalli; Maria Grazia De Gregorio; Mattia Zampieri; Elisa Fedele; Alessia Tomberli; Chiara Chiriatti; Alberto Marchi; Iacopo Olivotto
Journal:  Curr Cardiol Rep       Date:  2020-01-28       Impact factor: 2.931

Review 2.  Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week.

Authors:  Barry J Maron; Martin S Maron; Bradley A Maron; Joseph Loscalzo
Journal:  J Am Coll Cardiol       Date:  2019-04-23       Impact factor: 24.094

Review 3.  Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging.

Authors:  Takeshi Kitai; Andrew Xanthopoulos; Shoko Nakagawa; Natsuko Ishii; Masashi Amano; Filippos Triposkiadis; Chisato Izumi
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-25

4.  Discordant clinical features of identical hypertrophic cardiomyopathy twins.

Authors:  Giuliana G Repetti; Yuri Kim; Alexandre C Pereira; Jodie Ingles; Mark W Russell; Neal K Lakdawala; Carolyn Y Ho; Sharlene Day; Christopher Semsarian; Barbara McDonough; Steven R DePalma; Daniel Quiat; Eric M Green; Christine E Seidman; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 12.779

5.  Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?

Authors:  Myriam Lafreniere-Roula; Yoav Bolkier; Laura Zahavich; Jacob Mathew; Kristen George; Judith Wilson; Elizabeth A Stephenson; Leland N Benson; Cedric Manlhiot; Seema Mital
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

6.  Cardiovascular Diseases That Have Emerged From the Darkness.

Authors:  Barry J Maron; Martin S Maron; Mathew S Maurer; Ethan J Rowin; Bradley A Maron; Nazzareno Galiè
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

7.  Winter Is Coming: The Slippery Slope of Defining Disease and the Implications for Hypertrophic Cardiomyopathy.

Authors:  Ethan J Rowin; Martin S Maron
Journal:  JACC Case Rep       Date:  2022-01-19

8.  Subclinical Hypertrophic Cardiomyopathy in Elite Athletes: Knowledge Gaps Persist.

Authors:  Fiona Chan; Tim Lockie; Lorenzo Monserrat; James C Moon; Gabriella Captur
Journal:  JACC Case Rep       Date:  2022-01-19

Review 9.  Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere.

Authors:  Gabrielle Norrish; Ella Field; Juan P Kaski
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.